Short communicationPublished 24 Apr 2021

Metabolic Reprogramming in Triple-Negative Breast Cancer: Covid 19

Authors: Paola M Brown

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The COVID-19 pandemic has necessitated the development of breast cancer treatment prioritisation policies, with patients with advanced disease, such as triple-negative breast cancer (TNBC), receiving top priority for clinical intervention. We summarise how COVID-19 has affected TNBC management so far and highlight areas where more data is required to fine-tune changing guidelines. TNBC management during the pandemic poses problems beyond the limits of overburdened healthcare systems, due to the immunocompromised state of most TNBC patients seeking treatment. During the COVID-19 outbreak, we performed a literature review of clinical recommendations for both primary and targeted TNBC therapeutic methods, noting improvements in treatment timing and drugs of choice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in European Journal of Clinical Oncology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEuropean Journal of Clinical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Paola M Brown”